Amaia Lujambio
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Oncology top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Scott W. LoweManel EstellerRomain DonnéMontse Sánchez‐CéspedesSantiago RoperoSimona RossiGeorge A. CalinMarina Ruiz de Galarreta
- Topics
- Immunotherapy and Immune Responses (10 papers)Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Epigenetics and DNA Methylation (9 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Amaia Lujambio
54 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 4.2k
- Cancer Research 2.8k
- Oncology 1.2k
- Immunology 764
- Pulmonary and Respiratory Medicine 631
Countries citing papers authored by Amaia Lujambio
This map shows the geographic impact of Amaia Lujambio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amaia Lujambio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amaia Lujambio more than expected).
Fields of papers citing papers by Amaia Lujambio
This network shows the impact of papers produced by Amaia Lujambio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amaia Lujambio. The network helps show where Amaia Lujambio may publish in the future.
Co-authorship network of co-authors of Amaia Lujambio
This figure shows the co-authorship network connecting the top 25 collaborators of Amaia Lujambio. A scholar is included among the top collaborators of Amaia Lujambio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amaia Lujambio. Amaia Lujambio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 32 | |
| 5 | 5 | |
| 6 | Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinomabreakdown → | 342 |
| 7 | 16 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 19 | |
| 11 | 17 | |
| 12 | 18 | |
| 13 | 35 | |
| 14 | 25 | |
| 15 | 206 | |
| 16 | 100 | |
| 17 | Non-Cell-Autonomous Tumor Suppression by p53breakdown → | 615 |
| 18 | 48 | |
| 19 | The microcosmos of cancerbreakdown → | 917 |
| 20 | Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cellsbreakdown → | 729 |
About Amaia Lujambio
Amaia Lujambio is a scholar working on Hepatology, Cancer Research and Immunology, having authored 54 papers that have together received 6.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Cancer Research (2.8k citations), Hepatology (536 citations) and Molecular Biology (4.2k citations). Amaia Lujambio has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Scott W. Lowe, Manel Esteller, Romain Donné, Montse Sánchez‐Céspedes, Santiago Ropero, Simona Rossi, George A. Calin, Marina Ruiz de Galarreta, Luis M. Montuenga and David Blanco. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.